United Theranostics closed a $15 million senior debt facility with Old National Bank. The company will use proceeds from the facility to fund ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

United Theranostics is a national leader in providing cutting-edge radiopharmaceutical therapy and advanced molecular imaging in a comfortable, patient-centric outpatient setting. The Company is ...

This study utilizes bibliometric analysis to investigate the research landscape of FAP-directed cancer theranostics, focusing ...

The company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...

BAMF Health’s new charitable foundation received a $100,000 donation from a donor who’s described as a pioneer in molecular ...

Diverse Applications: FAPI-based radiotracers have shown promising results in diagnosing various cancers, particularly gastrointestinal malignancies, and have potential applications in inflammatory ...

Radiopharm Theranostics Ltd.’s radiotracer RAD-101 (F18-Pivalate) successfully detected brain metastases in a variety of primary solid tumors in a phase II study.

In recent years, there has been a growing interest in the field of novel theranostics, which encompasses both Positron emission tomography (PET) imaging and radionuclide therapy. Theranostics aims ...

JUPITER, Fla., Jan. 28, 2025 /PRNewswire/ -- Florida Theranostics is proud to announce the successful installation of the state-of-the-art VERITON-CT 400 from Spectrum Dynamics Medical ...

PET scans use fluorodeoxyglucose (FDG), a radioactive form of glucose, to show how aggressively tumours consume glucose ...

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD ...